Maximal respiratory pressure after COVID‐19 compared with reference material in healthy adults: A prospective cohort study (The SECURe study)

Abstract

Abstract After COVID‐19 long term respiratory symptoms and reduced lung function including maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) have been reported. However, no studies have looked at MIP and MEP in all disease groups and the reference materials collection methods differ substantially. We aimed to determine MIP and MEP in individuals after COVID‐19 infection with different disease severity using reference material of healthy control group obtained using the same standardized method. Patients with COVID‐19 were included March 2020–March 2021 at Rigshospitalet, Denmark. MIP and MEP were measured using microRPM. Predicted MIP and MEP were calculated using reference material obtained from 298 healthy adults aged 18–97 years using the same method. In SECURe, 145 participants were measured median 5 months after COVID‐19 diagnosis and of these 16% had reduced MIP and/or MEP. There was reduced spirometry and total lung capacity, but not reduced diffusion capacity in those with abnormal MIP and/or MEP compared with normal MIP and MEP. Of those with reduced MIP and/or MEP at 5 months, 80% still had reduced MIP and/or MEP at 12 months follow‐up. In conclusion, few have reduced MIP and/or MEP 5 months after COVID‐19 and little improvement was seen over time.

Keywords

• COVID‐19
• DALFUMAT
• respiratory muscle strength, reference values, SECURe